SCHEMBL4663676

SCHEMBL4663676

N#CC(C(=O)O)C(c1cccc2ccccc12)c1cccc2ccccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
CYP2C9 P11712 3/20 0.42
CYP2C19 P33261 3/20 0.42
HPGD P15428 2/20 0.42
HTT P42858 2/20 0.42
CYP1A2 P05177 2/20 0.42
NR4A1 P22736 1/20 0.41
NR4A2 P43354 1/20 0.41
NR4A3 Q92570 1/20 0.41
ACP3 P15309 4/20 0.40
HSP90AA1 P07900 1/20 0.38
MAPT P10636 1/20 0.38
CTSG P08311 1/20 0.38
CMA1 P23946 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ALOX5 P09917 1/20 0.38
CDC25B P30305 1/20 0.37
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4660174 0.92 ALOX5 (0.39) ALDH1A1CYP2C9CYP2C19HPGDHTT
SCHEMBL4661582 0.92 ALDH1A1 (0.39) ALDH1A1CYP2C9CYP2C19HPGDHTT
SCHEMBL4660208 0.90 CYP2C9 (0.45) ALDH1A1CYP2C9CYP2C19HPGDHTT
SCHEMBL6404486 0.89 KMT2A (0.46) ALDH1A1HPGDHTTTDP1LMNA
SCHEMBL4661588 0.89 ALDH1A1 (0.36) ALDH1A1CYP2C9CYP2C19HPGDHTT
SCHEMBL4659895 0.89 KMT2A (0.46) ALDH1A1HPGDHTTTDP1LMNA
SCHEMBL4659897 0.89 KMT2A (0.46) ALDH1A1HPGDHTTTDP1LMNA
SCHEMBL4660088 0.89 ALDH1A1 (0.41) ALDH1A1CYP2C9CYP2C19HPGDHTT
SCHEMBL4661533 0.89 ALDH1A1 (0.41) ALDH1A1CYP2C9CYP2C19HPGDHTT
SCHEMBL4659937 0.88 KDM4E (0.41) ALDH1A1CYP2C9CYP2C19HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299105-A1 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use WYETH (US) 2007-12-27 US claimed
EP-1620102-B1 3-(1-NAPHTHYL)-2-CYANOPROPANOIC ACID DERIVATIVES AS ESTROGEN RECEPTOR LIGANDS WYETH CORP (US) 2008-12-24 EP disclosed
US-20070299105-A1 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use WYETH (US) 2007-12-27 US disclosed
EP-1620102-A2 3-(1-NAPHTHYL)-2-CYANOPROPANOIC ACID DERIVATIVES AS ESTROGEN RECEPTOR LIGANDS Wyeth (US) 2006-02-01 EP disclosed
US-20050256132-A1 Use of ER selective NF-kB inhibitors for the treatment of sepsis WYETH (US) 2005-11-17 US disclosed
US-20050004164-A1 2-Cyanopropanoic acid amide and ester derivatives and methods of their use WYETH 2005-01-06 US disclosed
WO-2004099150-A2 3-(1-NAPHTHYL)-2-CYANOPROPANOIC ACID DERIVATIVES AS ESTROGEN RECEPTOR LIGANDS WYETH (US) 2004-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256132-A1 Use of ER selective NF-kB inhibitors for the treatment of sepsis NFKBIA, IKBKB, NFKB2 ALDH1A1 4483/4885CYP2C9 2318/4885CYP2C19 2026/4885
US-20070299105-A1 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use HCAR2, PCCA, MCCC2 ALDH1A1 1159/4885CYP2C9 1433/4885CYP2C19 1959/4885
US-20050004164-A1 2-Cyanopropanoic acid amide and ester derivatives and methods of their use HCAR2, PCCA, MCCC2 ALDH1A1 1172/4885CYP2C9 1476/4885CYP2C19 1862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.